Skip to search formSkip to main contentSkip to account menu

GR 32191

Known as: GR-32191, GR32191 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1999
1999
5‐HT and the prostanoid TP receptor agonists, U46619 and I‐BOP, constricted the human umbilical artery with pEC50 values of 7.3±0… 
1998
1998
1. The actions of tumour necrosis factor-alpha (TNF-alpha) on the coronary circulation were investigated in the rat isolated… 
1994
1994
During revascularization of skeletal muscle lipid mediators are released that may have a role in the pathogenesis of reperfusion… 
1993
1993
Although it has been postulated that inflammatory cells cause the bronchial hyper‐responsiveness which is diagnostic of asthma [1… 
1992
1992
The question of whether pharmacological inhibition of the thromboxane A2 activity prevents cyclosporine-induced chronic renal… 
1990
1990
Functional and morphological studies were done in three groups of male Sprague-Dawley rats after removal of the right kidney and… 
1987
1987
In-vitro GR32191 is a potent and specific thromboxane receptor blocking drug on platelets, and vascular and airways smooth muscle…